Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases. — المؤلف: Uemura, Hirotsugu — International journal of clinical oncology 20190710
- المؤلف
- Uemura, Hirotsugu
- النشر
- International journal of clinical oncology 20190710
- الوصف
- 557-566 p.
- الموضوعات
- Administration, Intravenous؛ Aged؛ Anemia؛ Bone Neoplasms؛ Follow-Up Studies؛ Hematologic Diseases؛ Humans؛ Male